122.55€
+
2.30€ (1.91%)
End-of-day quote: 05/15/2024
ENXTBR:UCB
UCB Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | NYSE | Outperform | $787.02 | $636.99 | 0.00% | 9 | $708.64B |
| JNJ | Johnson & Johnson | NYSE | Outperform | $152.67 | $174.55 | 0.00% | 3 | $367.43B |
| MRK | Merck | NYSE | Outperform | $131.73 | $130.51 | 0.00% | 11 | $333.65B |
| ABBV | AbbVie | NYSE | Outperform | $163.79 | $178.42 | 0.00% | 11 | $289.23B |
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $599.02 | $591.94 | 0.00% | 1 | $228.66B |
| NOVN | Novartis | SWX | Hold | CHF93.30 | CHF105.00 | 0.00% | 9 | CHF190.37B |
| AMGN | Amgen | NasdaqGS | Outperform | $319.04 | $303.65 | 0.00% | 8 | $171.14B |
| SAN | Sanofi | ENXTPA | Outperform | 90.56€ | 102.80€ | 0.00% | 9 | 113.21€B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $44.55 | $58.15 | 0.00% | 10 | $90.31B |
| CSL | CSL | ASX | Outperform | $283.05 | $205.51 | 0.00% | 5 | $136.78B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $67.01 | $87.82 | 0.00% | 14 | $83.48B |
| SHW | Sherwin Williams | NYSE | Outperform | $316.37 | $317.38 | 0.00% | 9 | $80.25B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.16k | ¥4.74k | 0.00% | 0 | ¥6.53T |
| LONN | Lonza Group | SWX | Buy | CHF532.20 | CHF516.89 | 0.00% | 8 | CHF38.38B |
| PPG | PPG Industries | NYSE | Outperform | $135.04 | $159.04 | 0.00% | 1 | $31.78B |
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $16.78 | $11.59 | 0.00% | 9 | $19.01B |
| 4523 | Eisai | TSE | Outperform | ¥6.86k | ¥9.58k | 0.00% | 0 | ¥1.97T |
| INCY | Incyte | NasdaqGS | Outperform | $57.05 | $77.05 | 0.00% | 8 | $12.01B |
| CRDA | Croda International Plc | LSE | Outperform | £48.83 | £65.12 | 0.00% | 6 | £6.81B |
| WCH | Wacker Chemie | XTRA | Outperform | 102.75€ | 145.36€ | 0.00% | 9 | 5.00€B |
| CLN | Clariant | SWX | Outperform | CHF14.30 | CHF16.11 | 0.00% | 6 | CHF4.67B |
| APLS | Apellis Pharmaceuticals | NasdaqGS | Outperform | $41.92 | $79.81 | 0.00% | 3 | $5.16B |
| OMER | Omeros | NasdaqGM | Hold | $4.17 | $13.00 | 0.00% | 2 | $241.63M |
| XFOR | X4 Pharmaceuticals | NasdaqCM | Outperform | $0.98 | $3.26 | 0.00% | 1 | $183.05M |
| DXB | Dimerix | ASX | $0.34 | $0.00 | 0.00% | 0 | $159.38M | |
| BLRX | BioLineRx | TASE | - | ₪0.16 | ₪1.39 | 0.00% | 0 | ₪302.07M |
| IFRX | InflaRx N.V. | NasdaqGS | Outperform | $1.40 | $9.44 | 0.00% | 2 | $70.66M |
| AKTX | Akari Therapeutics, Plc | NasdaqCM | - | $1.46 | $80.00 | 0.00% | 0 | $9.39M |
